Rachel Klemovitch05.30.23
SANUWAVE Health’s Board of Directors has appointed Morgan Frank as CEO. Frank replaces Kevin Richardson, whose served as board chairman since August 2022. Richardson will remain on the board and remain in an active role in the company as chief strategic officer.
Frank has previously served 19 years as founder of Manchester Management LLC, the company’s largest outside shareholder. He has provided guidance to over 100 public companies and provided guidance in long term strategic planning, investor relations, and business development strategy. Frank has 29 years of experience in U.S. public equity and capital markets, focusing on technology and life sciences and looks forward to working more deeply with SANUWAVE.
"Having now been SANUWAVE’s chairman for nearly a year, I believe strongly in the company and its mission to bring efficacious and cost-effective technology to the wound care market," said Frank in a press release. "This is a very exciting time in our lifecycle as we seek to rapidly expand our manufacturing and explore and expand our commercial and strategic options. I would like to thank Kevin for his role in assembling this impressive product suite and setting the stage for future success."
SANUWAVE Health is a provider of FDA-approved next generation wound care products. They focus on the research, development and commercialization of biological response-activating, non-invasive medical systems. SANUWAVE’s patented products repair and regenerate skin, vascular structures, and musculoskeletal tissue.
Frank has previously served 19 years as founder of Manchester Management LLC, the company’s largest outside shareholder. He has provided guidance to over 100 public companies and provided guidance in long term strategic planning, investor relations, and business development strategy. Frank has 29 years of experience in U.S. public equity and capital markets, focusing on technology and life sciences and looks forward to working more deeply with SANUWAVE.
"Having now been SANUWAVE’s chairman for nearly a year, I believe strongly in the company and its mission to bring efficacious and cost-effective technology to the wound care market," said Frank in a press release. "This is a very exciting time in our lifecycle as we seek to rapidly expand our manufacturing and explore and expand our commercial and strategic options. I would like to thank Kevin for his role in assembling this impressive product suite and setting the stage for future success."
SANUWAVE Health is a provider of FDA-approved next generation wound care products. They focus on the research, development and commercialization of biological response-activating, non-invasive medical systems. SANUWAVE’s patented products repair and regenerate skin, vascular structures, and musculoskeletal tissue.